Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Moran, S."'
Autor:
Greer JA; 1Massachusetts General Hospital.; 2Harvard Medical School, and., Moy B; 1Massachusetts General Hospital.; 2Harvard Medical School, and., El-Jawahri A; 1Massachusetts General Hospital.; 2Harvard Medical School, and., Jackson VA; 1Massachusetts General Hospital.; 2Harvard Medical School, and., Kamdar M; 1Massachusetts General Hospital.; 2Harvard Medical School, and., Jacobsen J; 1Massachusetts General Hospital.; 2Harvard Medical School, and., Lindvall C; 2Harvard Medical School, and.; 3Dana-Farber Cancer Institute, Boston, Massachusetts., Shin JA; 1Massachusetts General Hospital.; 2Harvard Medical School, and., Rinaldi S; 1Massachusetts General Hospital.; 2Harvard Medical School, and., Carlson HA; 1Massachusetts General Hospital.; 2Harvard Medical School, and., Sousa A; 1Massachusetts General Hospital.; 2Harvard Medical School, and., Gallagher ER; 1Massachusetts General Hospital., Li Z; 4University of Florida, Gainesville, Florida., Moran S; 5Massachusetts General Hospital Institute of Health Professions, Boston, Massachusetts., Ruddy M; 6University of Massachusetts Medical School, Worcester, Massachusetts., Anand MV; 7University of Rochester School of Medicine and Dentistry, Rochester, New York; and., Carp JE; 8Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania., Temel JS; 1Massachusetts General Hospital.; 2Harvard Medical School, and.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2022 Feb; Vol. 20 (2), pp. 136-143.
Autor:
Delaloge S; Department of Medicine, Institut Gustave Roussy, Villejuif, France. Electronic address: suzette.delaloge@gustaveroussy.fr., Cella D; Department of Medical Social Sciences, Feinberg School of Medicine at Northwestern University, Chicago., Ye Y; Puma Biotechnology Inc, Los Angeles, USA., Buyse M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Chan A; Breast Cancer Research Centre-WA & Curtin University, Perth, Australia., Barrios CH; Oncology Research Unit, Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil., Holmes FA; Texas Oncology, P.A, Houston, USA., Mansi J; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust and Biomedical Research Centre, King's College London, London, UK., Iwata H; Department of Breast Oncology, Aichi Cancer Center, Chikusa-ku, Nagoya, Japan., Ejlertsen B; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Moy B; Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, USA., Chia SKL; Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada., Gnant M; Department of Surgery and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria., Smichkoska S; University Clinic for Radiotherapy and Oncology, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia., Ciceniene A; Oncology Institute of Vilnius University, Vilnius, Lithuania., Martinez N; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Filipović S; Clinic of Oncology, Clinical Center Niš, Nis, Serbia., Ben-Baruch NE; Department of Oncology, Kaplan Medical Center, Rehovot, Israel., Joy AA; Cross Cancer Institute, Edmonton, Canada., Langkjer ST; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Senecal F; Northwest Medical Specialties PLLC, Tacoma, USA., de Boer RH; Department of Medical Oncology, Royal Melbourne Hospital, Melbourne, Australia., Moran S; Puma Biotechnology Inc, Los Angeles, USA., Yao B; Puma Biotechnology Inc, Los Angeles, USA., Bryce R; Puma Biotechnology Inc, Los Angeles, USA., Auerbach A; Puma Biotechnology Inc, Los Angeles, USA., Fallowfield L; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Martin M; Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Apr 01; Vol. 30 (4), pp. 567-574.
Autor:
Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, Grupo Español de Investigación en Cáncer de Mama (GEICAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Universidad Complutense, Madrid, Spain. Electronic address: mmartin@geicam.org., Holmes FA; Texas Oncology, Houston, TX, USA., Ejlertsen B; Rigshospitalet, Copenhagen, Denmark., Delaloge S; Institut Gustave Roussy, Villejuif, France., Moy B; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Iwata H; Aichi Cancer Center, Chikusa-ku, Nagoya, Japan., von Minckwitz G; Luisenkrankenhaus, German Breast Group Forschungs GmbH, Düsseldorf, Neulsenburg, Germany., Chia SKL; BC Cancer Agency, Vancouver, BC, Canada., Mansi J; Guy's and St Thomas' Hospital National Health Service Foundation Trust and Biomedical Research Centre, King's College, London, UK., Barrios CH; Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil., Gnant M; Department of Surgery and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria., Tomašević Z; Daily Chemotherapy Hospital, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Denduluri N; Virginia Cancer Specialists, Arlington, VA, USA., Šeparović R; University Hospital for Tumors, University Hospital Center 'Sestre milosrdnice', Zagreb, Croatia., Gokmen E; Ege University Faculty of Medicine, Izmir, Turkey., Bashford A; Auckland Hospital, Auckland, New Zealand., Ruiz Borrego M; Oncology Department, Hospital Universitario Virgen del Rocio, Seville, Spain., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Jakobsen EH; Department of Oncology, Lillebaelt Hospital, Vejle, Denmark., Ciceniene A; Oncology Institute of Vilnius University, Vilnius, Lithuania., Inoue K; Breast Oncology, Saitama Cancer Center, Kita-Adachi, Japan., Overkamp F; Oncologianova GmbH, Recklinghausen, Germany., Heijns JB; Department of Medical Oncology, Amphia Hospital, Breda, Netherlands., Armstrong AC; Department of Oncology, Christie Hospital Manchester, Manchester, UK., Link JS; Breastlink Medical Group Inc, Santa Ana, CA, USA., Joy AA; University of Alberta, Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada., Bryce R; Puma Biotechnology Inc, Los Angeles, CA, USA., Wong A; Puma Biotechnology Inc, Los Angeles, CA, USA., Moran S; Puma Biotechnology Inc, Los Angeles, CA, USA., Yao B; Puma Biotechnology Inc, Los Angeles, CA, USA., Xu F; Puma Biotechnology Inc, Los Angeles, CA, USA., Auerbach A; Puma Biotechnology Inc, Los Angeles, CA, USA., Buyse M; International Drug Development Institute, Louvain-la-Neuve, Belgium., Chan A; Breast Cancer Research Centre-Western Australia, Perth, WA, Australia; Curtin University, Perth, WA, Australia.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2017 Dec; Vol. 18 (12), pp. 1688-1700. Date of Electronic Publication: 2017 Nov 13.
Autor:
Crujeiras AB; Cancer Epigenetics and Biology Program (PEBC)Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain anabelencrujeiras@hotmail.com endocrine@usc.es mesteller@idibell.cat.; Laboratory of Molecular and Cellular EndocrinologyInstituto de Investigación Sanitaria (IDIS), Complejo Hospitalario Universitario de Santiago (CHUS/SERGAS), Santiago de Compostela University (USC), Santiago de Compostela, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn)Madrid, Spain., Diaz-Lagares A; Cancer Epigenetics and Biology Program (PEBC)Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.; Translational Medical Oncology Group (Oncomet)Instituto de Investigación Sanitaria (IDIS); Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS) and CIBER de Cancer (CIBERONC), Santiago de Compostela, Spain., Stefansson OA; Cancer Epigenetics and Biology Program (PEBC)Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.; Cancer Research LaboratoryFaculty of Medicine, University of Iceland, Reykjavic, Iceland., Macias-Gonzalez M; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn)Madrid, Spain.; Unidad de Gestión Clínica de Endocrinología y NutriciónInstituto de Investigación Biomédica de Málaga (IBIMA), Complejo Hospitalario de Málaga (Virgen de la Victoria), Universidad de Málaga, Málaga, Spain., Sandoval J; Cancer Epigenetics and Biology Program (PEBC)Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Cueva J; Translational Medical Oncology Group (Oncomet)Instituto de Investigación Sanitaria (IDIS); Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS) and CIBER de Cancer (CIBERONC), Santiago de Compostela, Spain., Lopez-Lopez R; Translational Medical Oncology Group (Oncomet)Instituto de Investigación Sanitaria (IDIS); Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS) and CIBER de Cancer (CIBERONC), Santiago de Compostela, Spain., Moran S; Cancer Epigenetics and Biology Program (PEBC)Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Jonasson JG; Department of Pathology and the Icelandic Cancer RegistryIcelandic Cancer society and Landspitali University Hospital, Reykjavik, Iceland., Tryggvadottir L; Department of Pathology and the Icelandic Cancer RegistryIcelandic Cancer society and Landspitali University Hospital, Reykjavik, Iceland., Olafsdottir E; Department of Pathology and the Icelandic Cancer RegistryIcelandic Cancer society and Landspitali University Hospital, Reykjavik, Iceland., Tinahones FJ; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn)Madrid, Spain.; Unidad de Gestión Clínica de Endocrinología y NutriciónInstituto de Investigación Biomédica de Málaga (IBIMA), Complejo Hospitalario de Málaga (Virgen de la Victoria), Universidad de Málaga, Málaga, Spain., Carreira MC; Laboratory of Molecular and Cellular EndocrinologyInstituto de Investigación Sanitaria (IDIS), Complejo Hospitalario Universitario de Santiago (CHUS/SERGAS), Santiago de Compostela University (USC), Santiago de Compostela, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn)Madrid, Spain., Casanueva FF; Laboratory of Molecular and Cellular EndocrinologyInstituto de Investigación Sanitaria (IDIS), Complejo Hospitalario Universitario de Santiago (CHUS/SERGAS), Santiago de Compostela University (USC), Santiago de Compostela, Spain anabelencrujeiras@hotmail.com endocrine@usc.es mesteller@idibell.cat.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn)Madrid, Spain., Esteller M; Cancer Epigenetics and Biology Program (PEBC)Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain anabelencrujeiras@hotmail.com endocrine@usc.es mesteller@idibell.cat.; Department of Physiological Sciences IISchool of Medicine, University of Barcelona and Instituto Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
Publikováno v:
Endocrine-related cancer [Endocr Relat Cancer] 2017 Jul; Vol. 24 (7), pp. 351-363. Date of Electronic Publication: 2017 Apr 25.
Autor:
Stefansson OA; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia 08908, Spain., Moran S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia 08908, Spain., Gomez A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia 08908, Spain., Sayols S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia 08908, Spain., Arribas-Jorba C; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia 08908, Spain., Sandoval J; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia 08908, Spain., Hilmarsdottir H; The Cancer Research Laboratory, Medical Faculty, University of Iceland, Reykjavik, Iceland., Olafsdottir E; The Icelandic Cancer Registry, Reykjavik, Iceland., Tryggvadottir L; The Icelandic Cancer Registry, Reykjavik, Iceland., Jonasson JG; The Icelandic Cancer Registry, Reykjavik, Iceland; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland., Eyfjord J; The Cancer Research Laboratory, Medical Faculty, University of Iceland, Reykjavik, Iceland., Esteller M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia 08908, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. Electronic address: mesteller@idibell.cat.
Publikováno v:
Molecular oncology [Mol Oncol] 2015 Mar; Vol. 9 (3), pp. 555-68. Date of Electronic Publication: 2014 Nov 05.
Autor:
Heyn H; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia 08907, Spain., Carmona FJ, Gomez A, Ferreira HJ, Bell JT, Sayols S, Ward K, Stefansson OA, Moran S, Sandoval J, Eyfjord JE, Spector TD, Esteller M
Publikováno v:
Carcinogenesis [Carcinogenesis] 2013 Jan; Vol. 34 (1), pp. 102-8. Date of Electronic Publication: 2012 Oct 10.
Autor:
Moran SL; Division of Plastic Surgery, University of Rochester Medical Center, NY 14642, USA., Serletti JM, Fox I
Publikováno v:
Plastic and reconstructive surgery [Plast Reconstr Surg] 2000 Dec; Vol. 106 (7), pp. 1527-31.
Autor:
Serletti JM; Division of Plastic Surgery, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. joseph_serletti@urmc.rochester.edu, Moran SL
Publikováno v:
Seminars in surgical oncology [Semin Surg Oncol] 2000 Oct-Nov; Vol. 19 (3), pp. 264-71.
Publikováno v:
AORN journal [AORN J] 2000 Feb; Vol. 71 (2), pp. 354-62; quiz 363-8.
Autor:
Moran SM
Publikováno v:
The Journal of the Oklahoma State Medical Association [J Okla State Med Assoc] 1981 Oct; Vol. 74 (10), pp. 327-33.